Transcriptomic characterization of plasma exosomes
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Maryland |
| Type of Government: | Federal |
| FSC Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Aug 20, 2026 |
| Due Date: | Aug 31, 2026 |
| Solicitation No: | NHGRI-09000 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Aug 20, 2026 09:20 am EDT
- Original Response Date: Aug 31, 2026 10:00 am EDT
- Inactive Policy: Manual
- Original Inactive Date: Sep 01, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code:
- NAICS Code:
-
Place of Performance:
Bethesda , MD 20892USA
The primary purpose of this acquisition is to obtain consumables and reagents essential for processing 650 plasma exosomal RNA samples for next generation sequencing. The Center for Research on Genomics and Global employs various molecular biology techniques to investigate the pathophysiology of cardiometabolic diseases and associated traits across diverse populations. This project aims to characterize the gene expression profile of plasma exosomes, which are implicated in several diseases. Plasma, a biological fluid collected via minimally invasive methods, serves as an indicator of health and disease status. Molecular analysis of plasma may further elucidate disease mechanisms and facilitate the discovery of novel biomarkers. Consumables and reagents supplied by New England Biolabs (NEB) are utilized in generating all necessary products for sequencing on the Illumina platform, the system currently available to NHGRI investigators through the core laboratory supporting this ongoing project.
- 3100 Center Drive Room 1B59
- Bethesda , MD 20892
- US
- ava miler
- ava.miller@nih.gov
- ayo p. doumatey
- doumateya@mail.nih.gov
- Aug 20, 2026 09:20 am EDTSpecial Notice (Original)
See Also
Follow Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and
DEPT OF DEFENSE
Due by 10/18/2028
Follow Strategic Contract Consolidation Announcement Active Contract Opportunity Notice ID Command_Control_and_Information_Network_(CPE_C2IN) Related Notice
DEPT OF DEFENSE
Follow Notice of Intent to Sole Source the Co-sponsorship of a Forum on
DEPT OF DEFENSE
Due by 11/18/2026
ID: BPM059686 Title: RFA: Maryland Pediatric Cancer Fund Research Grants Status: Open Due
State Government of Maryland
Due by 1/29/2027